Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Jermann

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2022
Preanalytical Variables and Sample Quality Control for Clinical Variant AnalysisIlaria Alborelli, Philip M Jermann
Therapeutische Umschau. Revue Therapeutique|September 10, 2019
[Current methods in molecular pathology]Jürgen Hench, Philip M Jermann, Ivana Bratic Hench, et al.
The Journal of Molecular Diagnostics : JMD|June 24, 2019
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing PlatformAndrea Garofoli, Viola Paradiso, Hesam Montazeri, et al.
Ejhaem|September 2, 2022
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALLMichael Medinger, Till Junker, Dominik Heim, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 6, 2022
Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine DiagnosticsSimon Haefliger, Katharina Marston, Ilaria Alborelli, et al.
International Journal of Molecular Sciences|September 28, 2023
European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid TumorsNicola Normanno, José Carlos Machado, Edoardo Pescarmona, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2022
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II studyAlfredo Addeo, Sacha I Rothschild, Lisa Holer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2022
Preanalytical Variables and Sample Quality Control for Clinical Variant AnalysisIlaria Alborelli, Philip M Jermann
Therapeutische Umschau. Revue Therapeutique|September 10, 2019
[Current methods in molecular pathology]Jürgen Hench, Philip M Jermann, Ivana Bratic Hench, et al.
The Journal of Molecular Diagnostics : JMD|June 24, 2019
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing PlatformAndrea Garofoli, Viola Paradiso, Hesam Montazeri, et al.
Ejhaem|September 2, 2022
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALLMichael Medinger, Till Junker, Dominik Heim, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 6, 2022
Prevalence of Molecular Alterations in a Swiss Cohort of 512 Colorectal Carcinoma Patients by Targeted Next-Generation Sequencing Analysis in Routine DiagnosticsSimon Haefliger, Katharina Marston, Ilaria Alborelli, et al.
International Journal of Molecular Sciences|September 28, 2023
European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid TumorsNicola Normanno, José Carlos Machado, Edoardo Pescarmona, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2022
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II studyAlfredo Addeo, Sacha I Rothschild, Lisa Holer, et al.
Pageof 1